Literature DB >> 10880368

Association between the molecular pathobiology of essential hypertension and thrombotic diseases.

T S Edgington1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10880368      PMCID： PMC1850190          DOI： 10.1016/S0002-9440(10)64509-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  8 in total

1.  Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture.

Authors:  R T Lee; F J Schoen; H M Loree; M W Lark; P Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-08       Impact factor: 8.311

Review 2.  The structural biology of expression and function of tissue factor.

Authors:  T S Edgington; N Mackman; K Brand; W Ruf
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

Review 3.  Sol Sherry lecture in thrombosis: how thrombin 'talks' to cells: molecular mechanisms and roles in vivo.

Authors:  S R Coughlin
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-04       Impact factor: 8.311

4.  Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study.

Authors:  J Willeit; S Kiechl; F Oberhollenzer; G Rungger; G Egger; E Bonora; M Mitterer; M Muggeo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

5.  Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.

Authors:  D N Müller; E M Mervaala; R Dechend; A Fiebeler; J K Park; F Schmidt; J Theuer; V Breu; N Mackman; T Luther; W Schneider; D Gulba; D Ganten; H Haller; F C Luft
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

6.  Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function.

Authors:  R Morishita; G H Gibbons; N Tomita; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

7.  Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms.

Authors:  G P Rossi; A Sacchetto; D Rizzoni; S Bova; E Porteri; G Mazzocchi; A S Belloni; M Bahcelioglu; G G Nussdorfer; A C Pessina
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

8.  Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.

Authors:  E P Feener; J M Northrup; L P Aiello; G L King
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808
  8 in total
  1 in total

1.  Prolylcarboxypeptidase promotes angiogenesis and vascular repair.

Authors:  Gregory N Adams; Evi X Stavrou; Chao Fang; Alona Merkulova; M Amer Alaiti; Kohsuke Nakajima; Toshifumi Morooka; Sergei Merkulov; Gretchen A Larusch; Daniel I Simon; Mukesh K Jain; Alvin H Schmaier
Journal:  Blood       Date:  2013-06-06       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.